The company also announced the 1,000th implantation of its InterPlate product.
“We are obviously delighted with our strong sales performance both year over year and sequentially, which we attribute to be the direct result of the master distribution agreement signed with Paradigm BioDevices in October 2009. We are also very pleased to have achieved the significant milestone of having our products implanted in more than 1,000 patients with excellent results,” RSB Spine CEO John A. Redmond said in the release.
Read the release on RSB Spine.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
